| scholarly article | Q13442814 |
| P50 | author | Lisa Hensley | Q4795006 |
| John Connor | Q37368402 | ||
| Claire Marie Filone | Q39189551 | ||
| P2093 | author name string | Feng Ni | |
| John K Snyder | |||
| G Guy Bushkin | |||
| Andrew Platt | |||
| Brian Honeyman | |||
| Erin N Hodges | |||
| Karla Boyd | |||
| Kyle Strom | |||
| P2860 | cites work | Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses | Q40178192 |
| Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening | Q40516689 | ||
| Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus | Q42873717 | ||
| Mutations that confer resistance to mycophenolic acid and ribavirin on sindbis virus map to the nonstructural protein nsP1 | Q42986339 | ||
| The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen | Q43545743 | ||
| In vitro and in vivo activities of T-705 and oseltamivir against influenza virus | Q44705790 | ||
| Natural polymorphisms and resistance-associated mutations in the fusion protein of respiratory syncytial virus (RSV): effects on RSV susceptibility to palivizumab | Q45360940 | ||
| The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. | Q45393162 | ||
| The interaction of antibody with the major surface glycoprotein of vesicular stornatitis virus II. Monoclonal antibodies to nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes | Q45805145 | ||
| Anti-MRSA agent discovery using diversity-oriented synthesis | Q46728360 | ||
| In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections | Q27481401 | ||
| Identification of Novel Epoxide Inhibitors of Hepatitis C Virus Replication Using a High-Throughput Screen | Q27481404 | ||
| New small molecule inhibitors of hepatitis C virus | Q27490441 | ||
| A broad-spectrum antiviral targeting entry of enveloped viruses | Q27491286 | ||
| Inhibition of heat-shock protein 90 reduces Ebola virus replication | Q28281834 | ||
| Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug | Q28342747 | ||
| T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. | Q30376917 | ||
| Diversity-oriented synthesis: exploring the intersections between chemistry and biology | Q33231454 | ||
| Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems | Q33653597 | ||
| Discovery of new antimalarial chemotypes through chemical methodology and library development | Q33875149 | ||
| Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism? | Q34122406 | ||
| The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase | Q34608397 | ||
| Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis | Q34805086 | ||
| Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agents | Q34906082 | ||
| Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent | Q35101611 | ||
| Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation | Q35785366 | ||
| Transcription and replication of nonsegmented negative-strand RNA viruses. | Q35857617 | ||
| Host-directed drug targeting of factors hijacked by pathogens | Q37224146 | ||
| Preferential translation of vesicular stomatitis virus mRNAs is conferred by transcription from the viral genome | Q39320821 | ||
| P433 | issue | 3 | |
| P921 | main subject | viral RNA synthesis | Q115189418 |
| P304 | page(s) | 424-433 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Chemistry and Biology | Q15758410 |
| P1476 | title | Identification of a broad-spectrum inhibitor of viral RNA synthesis: validation of a prototype virus-based approach | |
| P478 | volume | 20 |
| Q37209733 | A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals |
| Q50043318 | A polyamide inhibits replication of vesicular stomatitis virus by targeting RNA in the nucleocapsid. |
| Q40043376 | An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening |
| Q62383594 | Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules |
| Q56766112 | Approaches for antiviral probe development: new libraries, new mechanisms |
| Q28537731 | Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses |
| Q34042632 | Ebola virus (EBOV) infection: Therapeutic strategies |
| Q38953166 | Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes |
| Q38244444 | Reverse genetics systems as tools for the development of novel therapies against filoviruses |
| Q92154130 | Therapeutic strategies to target the Ebola virus life cycle |
| Q40144389 | Therapeutics Against Filovirus Infection |
| Q38980947 | Therapeutics for postexposure treatment of Ebola virus infection |
Search more.